About this trial
1. To characterise vaginal microbial community dynamics (bacterial and fungal) from different geographies in Africa to understand the microbial diversity that occurs in women with stable L. crispatus-dominant versus unstable vaginal microbiota. 2. To identify vaginal communities associated with low levels of inflammation in women from different geographies in Africa 3. To examine prevalence and diversity of HPV types circulating in the different geographies and their interaction with the vaginal microbiota 4. To create a biobank of stored samples that can be used in future studies and for the isolation of regionally representative bacterial strains.
Eligibility criteria
Qualifiers
Female at birth
Willing and able to provide informed consent for screening and cognitive ability to understand sampling procedures
Not pregnant
HIV negative on testing performed by study staff
Disqualifiers
Male at birth
Not willing to provide consent
Pregnant or actively trying to conceive/become pregnant in the next 10 weeks
Living with HIV or untreated STIs (CT, NG, TV) or bacterial vaginosis (Nugent > 3)
Trial design
Treatments tested in this trial
- None - observational study only
Treatment groups
Sponsors and collaborators
University of Cape Town
Lead sponsor
Desmond Tutu HIV Foundation
Collaborator
Kenya Medical Research Institute
Collaborator